Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
89%
Physical Activity
54%
Randomized Controlled Trial
43%
Meta-analysis
35%
Randomized Clinical Trial
34%
Lifestyle Intervention
31%
Intensive Lifestyle Intervention
28%
Pre-diabetes (pre-DM)
22%
Type 2 Diabetic Patients
21%
Hemoglobin A1c (HbA1c)
20%
Metformin
18%
Glycemic Control
17%
High-intensity Interval Training
17%
Gestational Diabetes Mellitus
17%
Care Groups
16%
Body Mass Index
16%
Glucose-lowering Drugs
14%
COVID-19
13%
Physical Activity Level
13%
Interval Walking Training
13%
Dapagliflozin
11%
95% Confidence Interval
11%
Overweight/obesity
11%
Precision Medicine
10%
Glycemic Variability
10%
Cardiac Structure
10%
Cardiac Function
10%
Patients with Diabetes
10%
Cardiorespiratory Fitness
10%
Exercise Effect
10%
Moderate-to-vigorous Physical Activity
9%
Insulin Resistance
9%
Health Technology Readiness
9%
Diabetes
9%
Exercise-based
8%
12-month Follow-up
8%
Intervention Group
8%
Leisure-time Physical Activity
8%
Aerobic Exercise
8%
Cardiovascular Risk
8%
Low Birth Weight
7%
Cardiometabolic Risk
7%
Obese Men
7%
Group-randomized Trial
7%
Gastric Emptying
7%
Body Composition
7%
Health-related Quality of Life
7%
Assessor-blinded
7%
Oral Glucose Tolerance Test
7%
Exercise Training
7%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Physical Activity
59%
Systematic Review
55%
Lifestyle Intervention
52%
Randomized Clinical Trials
37%
Randomized Controlled Trial
32%
Glucose
26%
Patient with Type 2 Diabetes
25%
Meta-Analysis
21%
Diabetes
21%
Body Mass Index
20%
Glycon
20%
Post-Hoc Analysis
18%
Glycemic Control
17%
Impaired Glucose Tolerance
17%
Glycemic
16%
Obesity
16%
Hemoglobin A1c
16%
Gestational Diabetes
13%
Care Group
13%
Arm
13%
Cardiovascular Disease
11%
Cell Function
11%
Dapagliflozin
11%
Personalized Medicine
10%
Oral Glucose Tolerance Test
10%
Diseases
10%
Leisure-Time Physical Activity
8%
Beta Cell
8%
Cardiovascular Risk
8%
Quality of Life
7%
Resistance Training
7%
Exercise
7%
Insulin Dependent Diabetes Mellitus
6%
Diabetes Prevention
6%
Adipose Tissue
5%
Insulin
5%
Cardiorespiratory
5%
Receptor
5%
Dose Response
5%
Observational Study
5%
Drug Therapy
5%
Cardiometabolic Risk
5%
Malignant Neoplasm
5%
Nursing and Health Professions
Physical Activity
75%
Maturity Onset Diabetes of the Young
58%
Systematic Review
27%
Obesity
22%
Clinical Trial
21%
Glucose
21%
Patient with Type 2 Diabetes
20%
Glycemic Control
17%
High-Intensity Interval Training
17%
Meta Analysis
17%
Impaired Glucose Tolerance
14%
Metformin
13%
Cardiovascular Disease
13%
Body Mass
13%
Hemoglobin A1c
12%
Cross-Sectional Study
12%
Diseases
12%
Cardiorespiratory Fitness
11%
Cardiovascular Risk
11%
Quality of Life
11%
Malignant Neoplasm
10%
Care Group
10%
Adherence
10%
COVID-19
10%
Insulin
9%
Oral Glucose Tolerance Test
8%
Cancer Rehabilitation
8%
Economic and Social Development
8%
Glucose Blood Level
7%
Body Composition
7%
Post Hoc Analysis
7%
Dapagliflozin
7%
Knee Osteoarthritis
7%
Exercise
7%
Telehealth
6%
Oxidative Stress
6%
Accelerometry
6%
Accelerometer
6%
Adverse Event
6%
Continuous Glucose Monitoring
5%
Knee Pain
5%
Glucose Level
5%
